Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 299-434-3 | CAS number: 93882-40-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Based physical chemical characteristics of the Substance there is high uncertainty regarding the applicability to the current in vitro studies, therefore the predictions are unlikely to be meaningful and/or represent the true hazard of the Substance. In conclusion it was considered appropriate to conduct an in vivo study approach to minimise the uncertainty for this Substance.
The Substance is considered to be amphiphilic and therefore would likely have surfactant characteristics, which is known to be falsely positive in the LLNA. Therefore a Guinea Pig Study, OECD 406, was conducted.
Based on the results of the OECD 406 study, the Substance s considered to be a contact sensitizer in guinea pigs as >15% of the test animals responded at challenge.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vitro
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
- Justification for type of information:
- The current in vitro studies were considered against the properties of the Substance. Extracts of the applicability and limitation from the respective OECD guidelines for each study have been highlight below.
OECD 442E (h-CLAT) – The guidelines state, “Test chemicals with a Log Kow greater than 3.5 tend to produce false negative results. Therefore negative results with test chemicals with a Log Kow greater than 3.5 should not be considered.”
OECD 442D (ARE-Nrf2 Luciferase Test Method) – The guidelines state, Test substances with a LogP of up to 5 have been successfully tested whereas extremely hydrophobic substances with a LogP above 7 are outside the known applicability of the test method.”
OECD 442C – The guidelines state, “The current prediction model cannot be used for complex mixture of unknown composition or for substances of unknown or variable composition, complex reaction products or biological materials (i.e. UVCB substances) due to the defined molar ration of test chemical and peptide.”
The Substance is considered to be extremely hydrophobic and has a Log Kow of >6.5 (Estimated 17-18.3) and additionally it is considered to be a UVCB. Data generated from the in vitro approaches are normally considered in the context of integrated approaches and individual studies are to be used as a weight of evidence. Based physical chemical characteristics of the Substance there is high uncertainty regarding the applicability to the current in vitro studies, therefore the predictions are unlikely to be meaningful and/or represent the true hazard of the Substance. In conclusion it was considered appropriate to conduct an in vivo study approach to minimise the uncertainty for this Substance. - Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 12th Ocotober 2015 - 15th March 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- Buehler test
- Justification for non-LLNA method:
- The LLNA is the study of choice for skin sensitisation. As detailed in the OECD 429 guideline, despite the advantages of the LLNA, it should be recognised that there are certain limitations that may necessitate the use of TG 406. Chemical groups such as metal salts, organometal, unsaturated compounds and surfactants have been known to be linked to false positive. The Substance is considered to be amphiphilic in nature and therefore would likely have surfactant characteristics, which are known to be falsely positive in the LLNA. Therefore a Guinea Pig Study, OECD 406, was selected to decrease the uncertainty of possible falsely positive effects.
- Specific details on test material used for the study:
- Batch (Lot) No.: E00268-011-113/E00350-276
Receipt Date: 28 Sep 2015
Retest Date: 26 Mar 2017
Physical Description: Brown waxy solid
Purity: 100%; dose calculations were not corrected for purity
Storage Conditions: Kept in a controlled room temperature area - Species:
- guinea pig
- Strain:
- Hartley
- Remarks:
- Hartley-derived albino guinea pig
- Sex:
- male/female
- Details on test animals and environmental conditions:
- Justification for Test System and Number of Animals: The Hartley-derived guinea pig was chosen as the animal model for this study as it is an accepted rodent species for preclinical toxicity testing by regulatory agencies. The total number of animals used in this study was considered to be the minimum required to properly characterize the effects of the test substance. This study was designed such that it did not require an unnecessary number of animals to accomplish its objectives. At this time, studies in laboratory animals provide the best available basis for extrapolation to humans and are required to support regulatory submissions. Acceptable models which do not use live animals currently do not exist.
Animal Identification: Each animal was identified by a cage card and plastic ear tag.
Environmental Acclimation: The animals were acclimated to their designated housing for at least 15 days before the first day of dosing.
Selection, Assignment, and Disposition of Animals: The animals chosen for study were arbitrarily selected from healthy animals. All animals received a detailed pretest observation prior to dosing. Only healthy animals were chosen for
study use. The male range-finding animals were approximately 6 weeks of age on the day prior to dosing with body weights of 358 grams and 370 grams. The female range-finding animals were approximately 7 weeks of age on the day prior to dosing with body weights of 360 grams and 362 grams.
The male main phase animals were approximately 7 weeks of age on the day prior to Induction 1 dosing with body weights ranging from 429 grams to 563 grams. The female main phase animals were approximately 8 weeks of age on the day prior to Induction 1 dosing with body
weights ranging from 402 grams to 515 grams.
The male second range-finding animals were approximately 10 weeks of age on the day prior to dosing with body weights of 596 grams and 644 grams. The female second range-finding animals were approximately 11 weeks of age on the day prior to dosing with body weights of 496 grams and 549 grams.
The disposition of all animals was documented in the Study Records.
Housing
The animals were pair housed (2 animals of the same sex and same dosing group together) throughout the study in polycarbonate cages containing direct bedding material. As an alternative, guinea pigs were individually housed in solid bottom cages containing a hiding
device and direct bedding material. Housing and care were as specified in the USDA Animal Welfare Act (9 CFR, Parts 1, 2, and 3) and as described in the Guide for the Care and Use of Laboratory Animals from the National Research Council.
Environmental Conditions
Temperatures of 68°F to 72°F (20°C to 22°C) with a relative humidity of 45% to 55% were maintained. A 12-hour light/12-hour dark cycle was maintained, except when interrupted for designated procedures. Ten or greater air changes per hour with 100% fresh air (no air
recirculation) were maintained in the animal rooms.
Food
PMI Nutrition International Certified Guinea Pig Chow No. 5026 was provided ad libitum throughout the study, except during designated procedures. The feed was analyzed by the supplier for nutritional components and environmental contaminants. Results of the dietary
analyses were provided by the supplier for each lot of diet and are on file at the Testing Facility. It is considered that there are no known contaminants in the feed that would interfere with the objectives of the study.
Water
Municipal tap water after treatment by reverse osmosis and ultraviolet irradiation was freely available to each animal via an automatic watering system, except during designated procedures. Water bottles were offered when required. The water is analyzed semi-annually for microbial contamination and for total dissolved solids, hardness, and various environmental contaminants. Results of these analyses are maintained on file at the Testing Facility. It is considered that there are no known contaminants in the water that could interfere with the outcome of the study.
Animal Enrichment
Beginning at receipt, guinea pigs were pair housed in solid bottom cages containing direct bedding material. As an alternative, guinea pigs were individually housed in solid bottom cages containing direct bedding material. When individually housed, a hiding comfort device (PVC
pipe) was provided. In addition, a Timothy Hay Cube was provided to each animal at least weekly.
Veterinary Care
Veterinary care was available throughout the course of the study; however, no examinations or treatments were required. - Route:
- epicutaneous, occlusive
- Vehicle:
- polyethylene glycol
- Concentration / amount:
- 100% / 0.3 mL
- Day(s)/duration:
- Day1, 7 & 14/ ~ 6 hours
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- corn oil
- Concentration / amount:
- 75%, 0.3 mL
- Day(s)/duration:
- Day 29/ 6 hour
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- 10 animals per sex for main study test group
5 animals per sex for main study control group - Details on study design:
- The dermal sensitization potential of the Substance was evaluated in Hartley-derived albino guinea pigs. Ten male and 10 female guinea pigs were topically treated with the Substance, as received, once per week, for 3 consecutive weeks. Following a 2-week rest period, a challenge was performed whereby the 20 test and 10 previously untreated (naïve) challenge control guinea pigs were topically treated with 75% the Substance in PEG 400.
- Challenge controls:
- On the day prior to challenge dose administration, the test, HCA test, challenge control, and HCA challenge control animals were weighed and the hair was removed from the right side of the animals. On the day following clipping (Day 28), Hilltop chambers were applied.
- Positive control substance(s):
- yes
- Remarks:
- a-Hexylcinnamaldehyde (HCA)
- Positive control results:
- The results of the HCA positive control study demonstrated that a valid test was performed and indicated that the test design would detect potential contact sensitizers.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 75%
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Clinical observations:
- No Susbstance related clinical signs were noted during the study.
- Remarks on result:
- positive indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 75%
- No. with + reactions:
- 12
- Total no. in group:
- 20
- Clinical observations:
- No Substance related clinical signs were noted during the study.
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 75%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No Substace related clinical signs were noted during the study.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 75%
- No. with + reactions:
- 3
- Total no. in group:
- 10
- Clinical observations:
- No Substace related clinical signs were noted during the study.
- Remarks on result:
- other:
- Remarks:
- 3 animals were observed with skin scores of 1
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 2.5%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 2.5%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 1%
- No. with + reactions:
- 9
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 1%
- No. with + reactions:
- 9
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
- Interpretation of results:
- Category 1 (skin sensitising) based on GHS criteria
- Conclusions:
- Based on the results of this study, Substance is considered to be a contact sensitizer in guinea pigs, as > 15% of the test animals responded at challenge.
- Executive summary:
The dermal sensitization potential of Substance was evaluated in Hartley-derived albino guinea pigs. Ten male and 10 female guinea pigs were topically treated with Substance, as received, once per week, for 3 consecutive weeks. Following a 2-week rest period, a challenge was performed whereby the 20 test and 10 previously untreated (naïve) challenge control guinea pigs were topically treated with 75% Substance in PEG 400.
An a-Hexylcinnamaldehyde (HCA) positive control group consisting of 10 HCA test and 10 HCA control guinea pigs was included in this study. The animals were treated as above with the HCA test animals receiving 5% w/v HCA in ethanol for induction and 2.5% and 1.0% w/v HCA in acetone for challenge.
Following challenge with 75% Substance in PEG 400, dermal scores of 1 or 2 were noted in 20/20 test animals at the 24-hour scoring interval. At the 48-hour scoring interval, dermal scores of 1 or 2 were noted in 20/20 test and 3/10 challenge control animals. Dermal reactions in the remaining challenge control animals were scores of 0 or ±. Group mean dermal scores were higher in the test animals (1.4 to 1.6) as compared to challenge control animals (0.0 to 0.6).
Based on the results of this study, Substance is considered to be a contact sensitizer in guinea pigs, as > 15% of the test animals responded at challenge. The results of the HCA positive control study demonstrated that a valid test was performed and indicated that the test design would detect potential contact sensitizers.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
Skin sensitisation (in vitro)
Based physical chemical characteristics of the Substance there is high uncertainty regarding the applicability to the current in vitro studies, therefore the predictions are unlikely to be meaningful and/or represent the true hazard of the Substance. In conclusion it was considered appropriate to conduct an in vivo study approach to minimise the uncertainty for this Substance.
Skin sensitisation (in vivo)
The Substance is considered to be amphiphilic and therefore would likely have surfactant characteristics, which is known to be falsely positive in the LLNA. Therefore a Guinea Pig Study, OECD 406, was conducted.
The dermal sensitization potential of Substance was evaluated in Hartley-derived albino guinea pigs. Ten male and 10 female guinea pigs were topically treated with Substance, as received, once per week, for 3 consecutive weeks. Following a 2-week rest period, a challenge was performed whereby the 20 test and 10 previously untreated (naïve) challenge control guinea pigs were topically treated with 75% Substance in PEG 400.
An a-Hexylcinnamaldehyde (HCA) positive control group consisting of 10 HCA test and 10 HCA control guinea pigs was included in this study. The animals were treated as above with the HCA test animals receiving 5% w/v HCA in ethanol for induction and 2.5% and 1.0% w/v HCA in acetone for challenge.
Following challenge with 75% Substance in PEG 400, dermal scores of 1 or 2 were noted in 20/20 test animals at the 24-hour scoring interval. At the 48-hour scoring interval, dermal scores of 1 or 2 were noted in 20/20 test and 3/10 challenge control animals. Dermal reactions in the remaining challenge control animals were scores of 0 or ±. Group mean dermal scores were higher in the test animals (1.4 to 1.6) as compared to challenge control animals (0.0 to 0.6).
Based on the results of this study, Substance is considered to be a contact sensitizer in guinea pigs, as > 15% of the test animals responded at challenge. The results of the HCA positive control study demonstrated that a valid test was performed and indicated that the test design would detect potential contact sensitizers.
Justification for classification or non-classification
The skin sensitisation study was conducted on the registered substance according to OECD Testing Guideline 406. Following a challenge exposure with the Substance, dermal scores of 1 or 2 were noted in 20/20 test animals at the 24 -hour observation, and in 20/20 test animals at 48 -hour observation. Score of 1 were also noted in 3/10 control animals at the 48 hour observation. Based on the result as >15% of the test animals responded at challenge, the test item was classified as sensitising according to Regulation (EC) No.1272/2008 on the Classification, Labelling and Packaging of Substances and Mixtures. The Substance will be classified as a skin sensitiser category 1 with the hazard statement H317: May cause an allergic skin reaction.There is insufficient data to classify into sub-categories.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.